2022
DOI: 10.1016/j.compbiomed.2022.105980
|View full text |Cite
|
Sign up to set email alerts
|

Pathological prognosis classification of patients with neuroblastoma using computational pathology analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 33 publications
0
9
0
Order By: Relevance
“…Histological data that may be utilised by ML for patient prognosis predictions was also discussed in this review [ 17 , 39 , 41 ]. Similarly, DL (DNN) approaches were proposed by Gheisari et al to classify digital images of NB into five groups [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Histological data that may be utilised by ML for patient prognosis predictions was also discussed in this review [ 17 , 39 , 41 ]. Similarly, DL (DNN) approaches were proposed by Gheisari et al to classify digital images of NB into five groups [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…The next step was the ML method for prognosis prediction, which included feature reduction, feature selection, and optimal model construction. For example, patient-level features were reduced to 25, after which the datasets were split by training and testing and underwent bootstrap resampling (1000×) [ 41 ]. A logistic regression was also used to incorporate features into a multivariate model, and then various feature combinations were tested and AUCs were generated.…”
Section: The Use Of Patient Data For Predicting Patient Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…Liu et al [ 174 ] advise a novel approach for neuroblastoma categorization using histopathological whole-slide images. The most frequent extra-cranial malignant tumor in young children is neuroblastoma.…”
Section: Deep Learning For Medical Image Analysis and Cadmentioning
confidence: 99%
“…However, the assessment of INPC is complex and subjective, and the analysis of the same patient by multiple pathologists may lead to inconsistent results. Moreover, the pathological heterogeneity of neuroblastoma can cause different differentiation grades at different parts of the same tumor, thus reducing the accurate evaluation of INPC [ 8 , 9 ]. Besides, the evaluation of MKI, an indicator of INPC, involves manual counting of 5000 cells under a microscope to determine the total number of cells undergoing karyorrhexis or in mitosis, which is a lengthy and laborious process [ 10 ].…”
Section: Introductionmentioning
confidence: 99%